
TY  - JOUR
AU  - Kanazi, Ghassan E.
AU  - Johnson, Ribert W.
AU  - Dworkin, Ribert H.
TI  - Neurology (61)
JO  - Pain Practice
JA  - Pain Practice
VL  - 1
IS  - 1
SN  - 1530-7085
UR  - https://doi.org/10.1111/j.1533-2500.2001.1011-61.x
DO  - doi:10.1111/j.1533-2500.2001.1011-61.x
SP  - 106
EP  - 106
PY  - 2001
AB  - Treatment of postherpetic neuralgia: an update. (University of Rochester School of Medicine and Dentistry, Rochester, NY) Drugs 2000;59:1113?1126. This article provided an update on recent developments in the treatment of postherpetic neuralgia (PHN). In clinical trials, the topical lidocaine patch, gabapentin, and controlled release oxycodone have been shown to provide superior pain relief in patients with PHN when compared with placebo. It has also been demonstrated that the tricyclic antidepressant nortriptyline provides equivalent analgesic benefit when compared with amitriptyline, but is better tolerated. Based on these results, nortriptyline can now be considered the preferred antidepressant for treatment of PHN. The topical lidocaine patch, gabapentin, and controlled release oxycodone all appear to be as effective as tricycline antidepressants in the treatment of patients with PHN, and the results of these recent studies suggest that each of these treatments should be considered early in the course of treatment. Additional controlled trials are needed to compare the efficacy and tolerability of these 4 treatments for patients with PHN.
ER  - 

TY  - JOUR
TI  - Clinical Nutrition Week 2009–Scientific Abstracts and Scientific Posters
JO  - Journal of Parenteral and Enteral Nutrition
JA  - JPEN J Parenter Enteral Nutr
VL  - 33
IS  - 2
SN  - 0148-6071
UR  - https://doi.org/10.1177/0148607109332066
DO  - doi:10.1177/0148607109332066
SP  - 181
EP  - 243
PY  - 2009
ER  - 

TY  - JOUR
TI  - Live Posters
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 34
IS  - S1
SN  - 0736-8046
UR  - https://doi.org/10.1111/pde.13195
DO  - doi:10.1111/pde.13195
SP  - S28
EP  - S99
PY  - 2017
ER  - 

TY  - JOUR
TI  - 36th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 18
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2008.00834.x
DO  - doi:10.1111/j.1600-0625.2008.00834.x
SP  - 274
EP  - 333
PY  - 2009
ER  - 

TY  - JOUR
AU  - Schnuelle, P.
AU  - Mundt, H. M.
AU  - Drüschler, F.
AU  - Schmitt, W. H.
AU  - Yard, B. A.
AU  - Krämer, B. K.
AU  - Benck, U.
TI  - Impact of spontaneous donor hypothermia on graft outcomes after kidney transplantation
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 18
IS  - 3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14541
DO  - doi:10.1111/ajt.14541
SP  - 704
EP  - 714
KW  - clinical research/practice
KW  - delayed graft function (DGF)
KW  - donors and donation: donation after brain death (DBD)
KW  - graft survival
KW  - kidney (allograft) function/dysfunction
KW  - kidney transplantation/nephrology
KW  - organ procurement
KW  - organ procurement and allocation
PY  - 2018
AB  - A previous donor intervention trial found that therapeutic hypothermia reduced delayed graft function (DGF) after kidney transplantation. This retrospective cohort study nested in the randomized dopamine trial (ClinicalTrials.gov identifier: NCT000115115) investigates the effects of spontaneous donor hypothermia (core body temperature <36°C) on initial kidney graft function, and evaluates 5-year graft survival. Hypothermia assessed by a singular measurement in the intensive care unit 4-20 hours before procurement was associated with less DGF after kidney transplantation (odds ratio [OR] 0.56, 95% confidence interval [CI] 0.34-0.91). The benefit was greater when need for more than a single posttransplant dialysis session was analyzed (OR 0.48, 95%CI 0.28-0.82). Donor dopamine ameliorated dialysis requirement independently from hypothermia in a temporal relationship with exposure (OR 0.93, 95%CI 0.87-0.98, per hour). A lower core body temperature in the donor was associated with lower serum creatinine levels before procurement, which may reflect lower systemic inflammation and attenuated renal injury from brain death. Despite a considerable effect on DGF, our study failed to demonstrate a graft survival advantage (hazard ratio [HR] 0.83, 95%CI 0.54-1.27), whereas dopamine treatment was associated with improved long-term outcome (HR 0.95, 95%CI 0.91-0.99 per hour).
ER  - 

AU  - Howard, Robin
AU  - Hirsch, Nicholas
AU  - Kitchen, Neil
AU  - Kullmann, Dimitri
AU  - Walker, Matthew
C7  - pp. 723-769
TI  - Disorders of Consciousness, Intensive Care Neurology and Sleep
SN  - 9781405134439
UR  - https://doi.org/10.1002/9781444311709.ch19
DO  - doi:10.1002/9781444311709.ch19
SP  - 723-769
KW  - disorders of consciousness, intensive care neurology and sleep
KW  - coma assessment
KW  - conjugate vertical eye movements
KW  - spontaneous roving eye movements
KW  - bulbar function
KW  - distinction of toxic and metabolic coma from structural coma
PY  - 2018
AB  - Summary This chapter contains sections titled: States of impaired consciousness Assessment of coma Determining brain death Neurological intensive care Intracranial pressure Traumatic brain injury General medical care on the neuromedical intensive care unit Neurology of general critical care Sleep and it's disorders Classification of sleep disorders Acknowledgement References
ER  - 

TY  - JOUR
TI  - Abstract of 29th Regional Congress of the ISBT
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 114
IS  - S1
SN  - 9781405134439
UR  - https://doi.org/10.1111/vox.12792
DO  - doi:10.1111/vox.12792
SP  - 5
EP  - 240
PY  - 2019
ER  - 

TY  - JOUR
TI  - Administrative Operations Section
JO  - Transfusion
VL  - 51
IS  - s3
SN  - 9781405134439
UR  - https://doi.org/10.1111/j.1537-2995.2011.03301_2.x
DO  - doi:10.1111/j.1537-2995.2011.03301_2.x
SP  - 238A
EP  - 282A
PY  - 2011
ER  - 

TY  - JOUR
TI  - Speaker Abstracts
JO  - Transfusion Medicine
JA  - Transfusion Med
VL  - 23
IS  - s2
SN  - 9781405134439
UR  - https://doi.org/10.1111/tme.12070
DO  - doi:10.1111/tme.12070
SP  - 1
EP  - 29
PY  - 2013
ER  - 

AU  - (Sunny) Dzik, Walter H.
AU  - Murphy, Michael F.
C7  - pp. 1-10
TI  - Introduction
SN  - 9781119129417
UR  - https://doi.org/10.1002/9781119129431.ch1
DO  - doi:10.1002/9781119129431.ch1
SP  - 1-10
KW  - blood components
KW  - blood donations
KW  - cellular therapy
KW  - clinical research
KW  - infectious disease
KW  - patient blood management
KW  - transfusion medicine
KW  - transfusion risks
KW  - transfusion-transmitted diseases
PY  - 2013
AB  - Summary Twentieth century transfusion medicine was advanced by the leadership of many physicians, scientists and technologists and repeatedly incorporated new diagnostics and new therapeutics to improve patient care. Each year, approximately 100 million blood donations are made worldwide. A safe and adequate blood supply is now an essential infrastructure requirement of any modern national healthcare system. During the final two decades of the twentieth century, intense focus on screening blood donations for infectious diseases led to substantial progress in blood safety and a significant reduction in the risk of transfusion-transmitted diseases. With the advent of the twenty-first century, the landscape of transfusion risk shifted its emphasis towards non-infectious hazards. Cellular therapy is a major growth area in transfusion medicine. The ability to mobilise haematopoietic progenitor cells, then harvest them safely in bulk numbers, process, freeze and successfully reinfuse them as a stem cell tissue transplant has completely revolutionised the field of bone marrow transplantation.
ER  - 

AU  - Turner, Alexandra P.
AU  - Brad Farris III, Alton
AU  - Freitas, Alessandrina M.
AU  - Cendales, Linda C.
C7  - pp. 1023-1029
TI  - Histopathological Syndromes of Vascularized Composite Allograft Rejection and Recurrent Disease
SN  - 9781118870143
UR  - https://doi.org/10.1002/9781118873434.ch87
DO  - doi:10.1002/9781118873434.ch87
SP  - 1023-1029
KW  - clinical research/practice
KW  - vascularized composite and reconstructive transplantation
KW  - pathology/histopathology
KW  - biopsy
KW  - rejection
KW  - recurrent disease
PY  - 2013
AB  - Summary Vascularized composite allotransplantation (VCA) is a developing field for the reconstruction of multi-tissue defects unable to be ameliorated with autologous tissue. Thus far, over 90 patients have received a VCA worldwide. Essentially, all VCA recipients have experienced episodes of rejection. At the time this chapter was written, acute rejection episodes have been observed in up to 85% of VCA recipients within the first year. Due to the infrequent application of VCA, no single group has accumulated sufficient experience to determine histologic patterns of rejection. As such, this chapters focuses on the histopathological aspects of graft rejection within the context of the early stage of VCA development. We also provide a historic perspective of the study of VCA histopathology primed by the Banff Working Group, and considerations on non-alloimmune pathology.
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 56
IS  - S1
SN  - 9781118870143
UR  - https://doi.org/10.1002/hep.26040
DO  - doi:10.1002/hep.26040
SP  - 191A
EP  - 1144A
PY  - 2012
ER  - 

C7  - pp. i-xlii
TI  - Frontmatter
SN  - 9780470874295
UR  - https://doi.org/10.1002/9781118180310.fmatter
DO  - doi:10.1002/9781118180310.fmatter
SP  - i-xlii
PY  - 2012
AB  - Summary The prelims comprise: Half Title Title Copyright Dedication Contents Preface Contributors Biographies Acknowledgments Abbreviations
ER  - 

TY  - JOUR
TI  - 9TH ECE PROCEEDINGS
JO  - Epilepsia
VL  - 51
IS  - s4
SN  - 9780470874295
UR  - https://doi.org/10.1111/j.1528-1167.2010.02658.x
DO  - doi:10.1111/j.1528-1167.2010.02658.x
SP  - 1
EP  - 189
PY  - 2010
ER  - 

TY  - JOUR
AU  - Orlandi, Richard R.
AU  - Kingdom, Todd T.
AU  - Hwang, Peter H.
AU  - Smith, Timothy L.
AU  - Alt, Jeremiah A.
AU  - Baroody, Fuad M.
AU  - Batra, Pete S.
AU  - Bernal-Sprekelsen, Manuel
AU  - Bhattacharyya, Neil
AU  - Chandra, Rakesh K.
AU  - Chiu, Alexander
AU  - Citardi, Martin J.
AU  - Cohen, Noam A.
AU  - DelGaudio, John
AU  - Desrosiers, Martin
AU  - Dhong, Hun-Jong
AU  - Douglas, Richard
AU  - Ferguson, Berrylin
AU  - Fokkens, Wytske J.
AU  - Georgalas, Christos
AU  - Goldberg, Andrew
AU  - Gosepath, Jan
AU  - Hamilos, Daniel L.
AU  - Han, Joseph K.
AU  - Harvey, Richard
AU  - Hellings, Peter
AU  - Hopkins, Claire
AU  - Jankowski, Roger
AU  - Javer, Amin R.
AU  - Kern, Robert
AU  - Kountakis, Stilianos
AU  - Kowalski, Marek L.
AU  - Lane, Andrew
AU  - Lanza, Donald C.
AU  - Lebowitz, Richard
AU  - Lee, Heung-Man
AU  - Lin, Sandra Y.
AU  - Lund, Valerie
AU  - Luong, Amber
AU  - Mann, Wolf
AU  - Marple, Bradley F.
AU  - McMains, Kevin C.
AU  - Metson, Ralph
AU  - Naclerio, Robert
AU  - Nayak, Jayakar V.
AU  - Otori, Nobuyoshi
AU  - Palmer, James N.
AU  - Parikh, Sanjay R.
AU  - Passali, Desiderio
AU  - Peters, Anju
AU  - Piccirillo, Jay
AU  - Poetker, David M.
AU  - Psaltis, Alkis J.
AU  - Ramadan, Hassan H.
AU  - Ramakrishnan, Vijay R.
AU  - Riechelmann, Herbert
AU  - Roh, Hwan-Jung
AU  - Rudmik, Luke
AU  - Sacks, Raymond
AU  - Schlosser, Rodney J.
AU  - Senior, Brent A.
AU  - Sindwani, Raj
AU  - Stankiewicz, James A.
AU  - Stewart, Michael
AU  - Tan, Bruce K.
AU  - Toskala, Elina
AU  - Voegels, Richard
AU  - Wang, De Yun
AU  - Weitzel, Erik K.
AU  - Wise, Sarah
AU  - Woodworth, Bradford A.
AU  - Wormald, Peter-John
AU  - Wright, Erin D.
AU  - Zhou, Bing
AU  - Kennedy, David W.
TI  - International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
JO  - International Forum of Allergy & Rhinology
JA  - Int Forum Allergy Rhinol.
VL  - 6
IS  - S1
SN  - 9780470874295
UR  - https://doi.org/10.1002/alr.21695
DO  - doi:10.1002/alr.21695
SP  - S22
EP  - S209
KW  - rhinosinusitis
KW  - chronic rhinosinusitis
KW  - acute rhinosinusitis
KW  - recurrent acute rhinosinusitis
KW  - evidence-based medicine
KW  - systematic review
KW  - endoscopic sinus surgery
PY  - 2016
AB  - Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham, MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav Chawdhary, MD7, Philip Chen, MD8, John P. Dahl, MD, PhD9, Anthony Del Signore, MD10, Carrie Flanagan, MD11, Daniel N. Frank, PhD12, Kai Fruth, MD, PhD13, Anne Getz, MD14, Samuel Greig, MD15, Elisa A. Illing, MD16, David W. Jang, MD17, Yong Gi Jung, MD18, Sammy Khalili, MD, MSc19, Cristobal Langdon, MD20, Kent Lam, MD21, Stella Lee, MD22, Seth Lieberman, MD23, Patricia Loftus, MD24, Luis Macias-Valle, MD25, R. Peter Manes, MD26, Jill Mazza, MD27, Leandra Mfuna, MD28, David Morrissey, MD29, Sue Jean Mun, MD30, Jonathan B. Overdevest, MD, PhD31, Jayant M. Pinto, MD32, Jain Ravi, MD33, Douglas Reh, MD34, Peta L. Sacks, MD35, Michael H. Saste, MD36, John Schneider, MD, MA37, Ahmad R. Sedaghat, MD, PhD38, Zachary M. Soler, MD39, Neville Teo, MD40, Kota Wada, MD41, Kevin Welch, MD42, Troy D. Woodard, MD43, Alan Workman44, Yi Chen Zhao, MD45, David Zopf, MD46 Contributing Author Affiliations 1Universidad de Barcelona; 2University of Pennsylvania; 3Louisiana State University Health Sciences Center; 4Universidade de S?o Paulo; 5ENT Specialists of Illinois; 6University of Arizona; 7University of Oxford; 8University of Texas; 9University of Indiana; 10Mount Sinai Beth Israel; 11Emory University; 12University of Colorado; 13Wiesbaden, Germany; 14University of Colorado; 15University of Alberta; 16University of Alabama at Birmingham; 17Duke University; 18Sungkyunkwan University; 19University of Pennsylvania; 20Universidad de Barcelona; 21Northwestern University; 22University of Pittsburgh; 23New York University; 24Emory University; 25University of British Columbia; 26Yale University School of Medicine; 27Private Practice; 28Department of Otolaryngology, Hôtel-Dieu Hospital, Centre de Recherche du Centre Hospitalier de l'Université de Montréal; 29University of Adelaide; 30Pusan National University; 31University of California, San Francisco; 32University of Chicago; 33University of Auckland; 34Johns Hopkins University; 35University of New South Wales, Australia; 36Stanford University; 37Washington University; 38Harvard Medical School; 39Medical University of South Carolina; 40Singapore General Hospital; 41Taho University; 42Northwestern University; 43Cleveland Clinic Foundation; 44University of Pennsylvania; 45University of Adelaide; 46University of Michigan
ER  - 

TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks. 46 Annual Meeting October 23–28, 1993
JO  - Transfusion
VL  - 33
IS  - S9
SN  - 9780470874295
UR  - https://doi.org/10.1111/j.1537-2995.1993.tb02684.x
DO  - doi:10.1111/j.1537-2995.1993.tb02684.x
SP  - 1s
EP  - 78s
PY  - 1993
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S4
SN  - 9780470874295
UR  - https://doi.org/10.1111/tri.12701
DO  - doi:10.1111/tri.12701
SP  - 134
EP  - 276
PY  - 2015
ER  - 

TY  - JOUR
TI  - ILTS
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 12
IS  - 5
SN  - 9780470874295
UR  - https://doi.org/10.1002/lt.20832
DO  - doi:10.1002/lt.20832
SP  - C1
EP  - C142
PY  - 2006
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 72 to 394)
JO  - Clinical Oral Implants Research
VL  - 19
IS  - 9
SN  - 9780470874295
UR  - https://doi.org/10.1111/j.1600-0501.2008.01625_2.x
DO  - doi:10.1111/j.1600-0501.2008.01625_2.x
SP  - 860
EP  - 967
PY  - 2008
ER  - 

TY  - JOUR
AU  - Ueda, Yoshihide
AU  - Marusawa, Hiroyuki
AU  - Ichinohe, Tatsuo
AU  - Kadowaki, Norimitsu
AU  - Uchiyama, Takashi
AU  - Chiba, Tsutomu
TI  - Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 5
SN  - 9780470874295
UR  - https://doi.org/10.1002/ajh.21388
DO  - doi:10.1002/ajh.21388
SP  - 315
EP  - 316
PY  - 2009
ER  - 
